Oanh Kim Pham, Thuy Bich Duong, Tho Vinh Phan, Trung Ngoc Truong, Duong Thi Hai Ha, Hao Van Nguyen, Vu Thi Minh Hien, Trinh Huu Khanh Dong, Nguyen Lam Vuong, Lam Minh Yen, Sophie Yacoub, Catherine Louise Thwaites, Dong Thi Hoai Tam
{"title":"Severe dengue in adults: Clinical features from the 2022 dengue outbreak at a Vietnamese tertiary hospital.","authors":"Oanh Kim Pham, Thuy Bich Duong, Tho Vinh Phan, Trung Ngoc Truong, Duong Thi Hai Ha, Hao Van Nguyen, Vu Thi Minh Hien, Trinh Huu Khanh Dong, Nguyen Lam Vuong, Lam Minh Yen, Sophie Yacoub, Catherine Louise Thwaites, Dong Thi Hoai Tam","doi":"10.1371/journal.pntd.0013589","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In Vietnam, dengue has been endemic for many years, with most cases reported in children. Recently, epidemiological data show an increasing frequency in adults, especially for severe dengue. An unprecedented post-COVID-19 surge resulted in an exceptionally high number of hospitalized dengue cases. We aim to describe the clinical phenotypes and outcomes in Vietnamese adults with severe dengue during the 2022 outbreak and explore host-related factors associated with disease variability and severity, through a retrospective study.</p><p><strong>Findings: </strong>A total of 891 cases were included, with mean age 29 ± 10 years. 284/891 (31.9%) patients had a BMI ≥ 25 kg/m2, and 240/891 (26.9%) had comorbidities. The predominant severe clinical phenotype was dengue shock syndrome (DSS): 737/891 (82.7%) patients. 107/891 (12%) DSS cases were associated with other severe manifestations. Severe hemorrhage accounted for 90/891 (10.1%) patients. Among cases with organ involvement (211/891 - 23.7%), hepatic impairment was observed in 196/891 (22%) patients, renal impairment 25/891 (2.8%), cardiac impairment 14/891 (1.6%) and neurological impairment 13/891 (1.5%). 250/737 (33.9%) DSS patients developing ≥ 1 episode of recurrent shock. They were younger than those without recurrent shock (25.3 vs 28.4 years, p = 0.007). Factors associated with recurrent shock episodes were: having BMI ≥ 25 (OR: 1.65; 95% CI: 1.18; 2.3), day of illness ≤ 5 (OR: 2.16; 95% CI: 1.51; 3.09) and prior COVID-19 infection (OR: 2.57; 95% CI: 1.62-4.06). Indicators for the \"associated severe phenotypes\" (DSS associated with severe hemorrhage, with organ impairment, or both) were older age (p = 0.018) and presence of comorbidities (p < 0.001) compared to the DSS alone phenotype. Overall, 98.1% of patients had a good recovery.</p><p><strong>Conclusions: </strong>Understanding the variability and complexity of severe dengue clinical manifestations, along with the different host factors associated with these features, will contribute to formulating suitable treatment guidelines for this at-risk population.</p>","PeriodicalId":49000,"journal":{"name":"PLoS Neglected Tropical Diseases","volume":"19 10","pages":"e0013589"},"PeriodicalIF":3.4000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PLoS Neglected Tropical Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1371/journal.pntd.0013589","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"PARASITOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: In Vietnam, dengue has been endemic for many years, with most cases reported in children. Recently, epidemiological data show an increasing frequency in adults, especially for severe dengue. An unprecedented post-COVID-19 surge resulted in an exceptionally high number of hospitalized dengue cases. We aim to describe the clinical phenotypes and outcomes in Vietnamese adults with severe dengue during the 2022 outbreak and explore host-related factors associated with disease variability and severity, through a retrospective study.
Findings: A total of 891 cases were included, with mean age 29 ± 10 years. 284/891 (31.9%) patients had a BMI ≥ 25 kg/m2, and 240/891 (26.9%) had comorbidities. The predominant severe clinical phenotype was dengue shock syndrome (DSS): 737/891 (82.7%) patients. 107/891 (12%) DSS cases were associated with other severe manifestations. Severe hemorrhage accounted for 90/891 (10.1%) patients. Among cases with organ involvement (211/891 - 23.7%), hepatic impairment was observed in 196/891 (22%) patients, renal impairment 25/891 (2.8%), cardiac impairment 14/891 (1.6%) and neurological impairment 13/891 (1.5%). 250/737 (33.9%) DSS patients developing ≥ 1 episode of recurrent shock. They were younger than those without recurrent shock (25.3 vs 28.4 years, p = 0.007). Factors associated with recurrent shock episodes were: having BMI ≥ 25 (OR: 1.65; 95% CI: 1.18; 2.3), day of illness ≤ 5 (OR: 2.16; 95% CI: 1.51; 3.09) and prior COVID-19 infection (OR: 2.57; 95% CI: 1.62-4.06). Indicators for the "associated severe phenotypes" (DSS associated with severe hemorrhage, with organ impairment, or both) were older age (p = 0.018) and presence of comorbidities (p < 0.001) compared to the DSS alone phenotype. Overall, 98.1% of patients had a good recovery.
Conclusions: Understanding the variability and complexity of severe dengue clinical manifestations, along with the different host factors associated with these features, will contribute to formulating suitable treatment guidelines for this at-risk population.
期刊介绍:
PLOS Neglected Tropical Diseases publishes research devoted to the pathology, epidemiology, prevention, treatment and control of the neglected tropical diseases (NTDs), as well as relevant public policy.
The NTDs are defined as a group of poverty-promoting chronic infectious diseases, which primarily occur in rural areas and poor urban areas of low-income and middle-income countries. Their impact on child health and development, pregnancy, and worker productivity, as well as their stigmatizing features limit economic stability.
All aspects of these diseases are considered, including:
Pathogenesis
Clinical features
Pharmacology and treatment
Diagnosis
Epidemiology
Vector biology
Vaccinology and prevention
Demographic, ecological and social determinants
Public health and policy aspects (including cost-effectiveness analyses).